Scitara, an innovator in laboratory digital transformation, has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.
 
Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry. One of the programs within the portfolio, The Lab of the Future, sets out an industry manifesto creating a pathway to unlock the value of the pharmaceutical and biopharmaceutical sectors by realizing strategic IT and data-driven objectives to bring the laboratory of the future to reality. 
 
The Scitara goal is clear: to help companies in life sciences solve the laboratory data integration challenge that has stifled progress for decades. Its Scientific Integration Platform SIP, a cloud native infrastructure, facilitates a modern, fully connected laboratory with data standardization, data mobility, system flexibility, easily customizable workflows, and adaptability to a dynamic laboratory ecosystem.  
 
Chief technical officer at Scitara, Geoff Gerhardt, commented: “Bringing new drugs to market involves overcoming complex data management challenges in a highly regulated environment. Mobilizing scientific data from research through quality control (QC)/manufacturing is critical to accelerating the pace of bringing life-saving therapies to market. Digital technology has huge transformational potential but regulatory barriers have delayed its adoption compared to other industries.
 
“Joining BioPhorum gives us the opportunity to work in collaboration with other like-minded industry leaders to share our knowledge, decades of experience, and resources in data custodianship to help science turn data into useable knowledge.”
 
Lauren Morgan, IT Phorum lead at BioPhorum added: “Scitara is leading next generation digital transformation in the lab. This aligns perfectly with our strategic goal of creating an environment in which leaders in the international pharmaceutical and biopharmaceutical industries come together to share information and accelerate the pace of change – for the benefit of the whole industry.”
 
The Scitara SIP, powered by its Digital Lab Exchange DLX, integrates scientific data across the enterprise and, together with artificial intelligence (AI) and analytics tools, provides scientists with new insights to drive faster decision making – delivering data integrity in a fully compliant platform to meet the strict needs of regulated markets.
 
As BioPhorum members, Scitara will participate in presentations and members-only events alongside other industry leaders, to further the group’s collective knowledge on the lab of the future.